<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Chernobyl accident":1,
"Children":3,
"Paediatrics":1,
"Radiation":4,
"Secondary cancer":1,
"Thyroid cancer":89,
"Breast cancer":42,
"IL-21":1,
"IL-9":2,
"Th9 cell":1,
"BCSCs":1,
"Exosome":1,
"Invasion":13,
"RAB5B":1,
"miR-130a-3p":1,
"MiR-940":1,
"diagnosis":7,
"prognosis":18,
"Nasopharyngeal carcinoma":3,
"PI3K/AKT":1,
"PVT1":1,
"Tumor stem cell":1,
"miR-1207":1,
"Thyroid":42,
"fine-needle aspiration cytology":3,
"frozen section":2,
"nodule":2,
"Immunotherapy":6,
"Immunotoxicity":1,
"Nonsmall cell lung cancer":1,
"Pembrolizumab":2,
"Pericardial effusion":1,
"Cancer care":1,
"Case review meeting":1,
"Multidisciplinary approach":1,
"Multidisciplinary team":1,
"BRAF mutation":3,
"Case-control studies":2,
"Case-only studies":1,
"Papillary thyroid cancer":34,
"Passive smoking":1,
"Smoking":1,
"Familial adenomatous polyposis":1,
"thyroid cancer screening":1,
"FAP inhibitor":1,
"PET/CT":2,
"fibroblast activation protein":1,
"theranostics":1,
"tracer development":1,
"Graves’ disease":1,
"hemoglobin":1,
"multispectral optoacoustic tomography (MSOT)":1,
"thyroid nodule":23,
"Bethesda":1,
"Citología":1,
"Cytology":7,
"Nódulo tiroideo":1,
"Punción-aspiración con aguja fina":1,
"Artificial intelligence":2,
"Lymphatic metastasis":2,
"Multidetector computed tomography":1,
"CEP78":1,
"WDR62":1,
"lateral lymph node metastasis":1,
"Diagnostic efficiency":1,
"Fine-needle aspiration":9,
"Screening":1,
"Thyroid neoplasms":11,
"Ablation techniques":1,
"High-intensity focused ultrasound ablation":1,
"Interventional ultrasonography":1,
"Nodular goiter":1,
"Pain management":1,
"Familial papillary thyroid carcinoma":1,
"Prognostic factor thyroid microcarcinoma":1,
"Thyroid microcarcinoma":1,
"Breast cancer cell":1,
"Doxorubicin resistance":1,
"NEMO SUMOylation":1,
"NF-κB":2,
"SENP2":1,
"Indeterminate response":1,
"Ongoing risk":1,
"Thyroglobulin":8,
"Ultrasensitive assay":1,
"SETTLE":1,
"histology":2,
"pediatric":3,
"SMAD4":1,
"adenocarcinoma":3,
"carcinoma":9,
"immunohistochemistry":9,
"neoplasm":1,
"pancreas":2,
"protein":1,
"The Cancer Genome Atlas":2,
"microRNA":4,
"overall survival":4,
"papillary thyroid carcinoma":64,
"prognostic markers":1,
"Breast imaging reporting and data system":1,
"Diagnostic performance":1,
"Shear wave velocity":1,
"Virtual touch tissue imaging quantification":2,
"Complication":2,
"Elderly":1,
"Geriatric":2,
"Thyroidectomy":18,
"2015 ATA guidelines":1,
"Extent of thyroidectomy":1,
"Long-term outcomes":1,
"Risk stratification":3,
"Esophageal squamous cell carcinoma (ESCC)":1,
"Ivor–Lewis esophagectomy":1,
"Total pharyngolaryngectomy (TPL)":1,
"NSCLC":2,
"PKM2":5,
"SRSF5":1,
"apoptosis":7,
"glycolysis":6,
"proliferation":15,
"carcinogenesis":1,
"drug resistance":1,
"hepatocellular carcinoma":5,
"oncogenes":1,
"tumour markers":1,
"Africa":1,
"Cancer incidence":1,
"Ecological analysis":1,
"Food availability":1,
"Nutrition transition":1,
"DNMT1":1,
"MGMT":1,
"MS-HRM":1,
"ctDNA":1,
"methylation":2,
"cartilage":1,
"laryngeal cancer":1,
"laser":2,
"transoral":2,
"transoral laser microsurgery":1,
"EMT":5,
"VHL":1,
"miR-21":1,
"Acromegaly":1,
"NF1":1,
"Primary hyperparathyroidism":2,
"Somatotroph adenoma":1,
"Thyroid follicular carcinoma":1,
"death":1,
"risk":3,
"Gastric parietal cell antibody":1,
"Oral leukoplakia":1,
"Oral precancer":1,
"Thyroglobulin antibody":1,
"Thyroid microsomal antibody":1,
"Cancer cell death":1,
"Cancer cell migration":1,
"IL-32":1,
"11β-HSD2":1,
"17β-HSD7":1,
"Mutual regulation":1,
"Receptors":1,
"Steroid sulfatase":1,
"mitochondrial respiration":1,
"targeted therapy":3,
"tigecycline":1,
"Anthracycline":1,
"Basal":1,
"Neo-adjuvant chemotherapy":1,
"Taxane":1,
"Triple negative":1,
"cytologic findings":1,
"follicular variant of papillary thyroid carcinoma":1,
"multinucleated giant cells":1,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":2,
"2,3′4,4′,5-Pentachlorobiphenyl":1,
"Cell proliferation":4,
"Hepatocellular carcinoma cells":1,
"follicular lesion of undetermined significance":2,
"follicular neoplasm/suspicious for follicular neoplasm":1,
"pediatric thyroid nodule":1,
"risks of malignancy":1,
"suspicious for malignancy":2,
"Anticorps anti-Scl70":1,
"Autoantibodies":2,
"Cancer":20,
"Crise rénale sclérodermique":1,
"Néoplasie":1,
"Renal Scleroderma crisis":1,
"Sclérodermie":1,
"Systemic sclerosis":1,
"ATM":1,
"Autophagy":5,
"Beclin 1":1,
"G2/M arrest":1,
"Tip60":1,
"Brain metastasis":1,
"Computer-aided diagnosis":3,
"Ultrasonography":12,
"Adrenal cortex":1,
"Adrenocortical carcinoma":1,
"DLK1":1,
"Remodeling":1,
"Steroidogenesis":1,
"Clinicopathologic features":1,
"Genetic mutations":2,
"Nasopharyngeal papillary adenocarcinoma":1,
"Thyroid-like":2,
"Hürthle cells":1,
"ThyroSeq":2,
"fine needle aspiration (FNA)":1,
"molecular":2,
"fluorescent in-situ hybridization":1,
"pharynx":1,
"synovial sarcoma":1,
"STRN-ALK":1,
"dedifferentiation":1,
"p53":2,
"poorly differentiated carcinoma":1,
"Diagnostic imaging":1,
"Lymph nodes":3,
"Salivary gland":1,
"Soft tissue":1,
"Tissue sampling":1,
"Air-flow assisted ionization":1,
"Data processing":1,
"Mass spectrometry imaging":2,
"Spatially resolved metabolomics":1,
"Tumor heterogeneity":1,
"NIS":1,
"dimerization":1,
"radioiodide uptake":1,
"cribriform-morular variant":1,
"familial adenomatous colon polyposis":1,
"lenvatinib":6,
"lung metastasis":1,
"Birthweight":1,
"Cohort":4,
"BRAF":8,
"Fibromatosis/fasciitis-like stroma":1,
"Mutation":5,
"SOX11":1,
"β-Catenin":6,
"Complications":3,
"Concurrent surgical resection":1,
"Esophageal squamous cell carcinoma":2,
"Head and neck cancer":5,
"Second primary malignancy":2,
"Simultaneous":1,
"Survival":9,
"Synchronous":1,
"Inflammation":2,
"L-thyroxine":2,
"Oral cancer":2,
"PD-L1":1,
"Resveratrol":1,
"IGSF1":1,
"metastasis":23,
"CASC2":1,
"CDK19":1,
"Chemoresistance":3,
"miR-18a-5p":1,
"Hyperthyroidism":2,
"CD8+ T cell":1,
"Carcinome hépatocellulaire":1,
"Cutaneous adverse effects":1,
"Effets secondaires cutanés":1,
"Nodular-cystic eruption":1,
"Sorafenib":5,
"Sorafénib":1,
"Éruption nodulo-kystique":1,
"RET proto-oncogene":1,
"S409Y mutation":1,
"medullary thyroid carcinoma":12,
"multiple endocrine neoplasia type 2A":1,
"thyroid neoplasm":2,
"L-triiodothyronine":1,
"combination therapy":1,
"hypothyroidism":6,
"pharmacokinetics":1,
"thyroid hormone withdrawal":1,
"active surveillance":7,
"systematic review and meta-analysis":1,
"Grave's":1,
"nodules":1,
"2-D shear wave elastography":1,
"Conventional US":1,
"Immunohistochemical subtypes":1,
"epithelial":1,
"papillary":3,
"pigmented":1,
"sella":1,
"tumor":5,
"follicular neoplasm":1,
"growth kinetics":2,
"malignancy":3,
"volume doubling time":1,
"LncRNA":6,
"SNHG6":1,
"VASP":2,
"miR-26a":1,
"differentiated thyroid cancer":10,
"dynamic risk":1,
"risk of recurrence":1,
"Cell migration":2,
"TRIM63":1,
"Wnt/β-catenin signaling pathway":2,
"BC, breast cancer":1,
"BMI, body mass index":1,
"CI, confidence interval":1,
"CNS, central nervous system":1,
"Cohort study":1,
"DMF, dimethyl fumarate":1,
"DMT":1,
"DMT, disease modifying treatment":1,
"EBV, Epstein-Barr virus":1,
"GA, glatiramer acetate":1,
"Glossary: MS, multiple sclerosis":1,
"HL, Hodgkin lymphoma":1,
"ICD, International Classification of Diseases":1,
"IFN, interferon":1,
"IS, immunosuppressant":1,
"MRI, magnetic resonance image":1,
"Multiple sclerosis":1,
"OR, odds ratio":1,
"PPMS, primary progressive MS":1,
"RRMS, relapsing remitting MS":1,
"SPMS, secondary progressive MS":1,
"TFR, teriflunomide":1,
"Long non-coding RNA":2,
"MIAT":1,
"ceRNA":1,
"miR-212":1,
"low-risk cancer":1,
"nonsurgical treatment":1,
"Anticancer drug":1,
"Clinical trials":2,
"HDAC inhibitors":1,
"HDACs":1,
"TERT activation":1,
"copy number change":1,
"promoter activity":1,
"promoter mutation":1,
"CDKN1A":1,
"MTC":1,
"RET":8,
"SNP":1,
"meta-analysis":9,
"risk association":1,
"Calcitonin":6,
"DICER1":1,
"Hereditary medullary thyroid carcinoma":1,
"RET Oncogene":1,
"TRIP6":1,
"endometrial carcinoma":2,
"miR-589-5p":1,
"migration":9,
"ANKRD26":1,
"Expression analysis RET":1,
"RET rearrangement":1,
"RET/PTC":2,
"GEO":3,
"nomogram":5,
"radioactive iodine":5,
"surgical outcomes":1,
"3D printing":1,
"Medical image":1,
"Phantom":1,
"Diet":1,
"Dietary factors":1,
"Dietary patterns":1,
"EZR gene":1,
"TERT":4,
"polymorphism":1,
"Biomarker":7,
"HEIH":1,
"MiR-4458":1,
"SOCS1":2,
"Coexistence":1,
"Hashimoto’s disease":1,
"mucosa-associated lymphoid tissue lymphoma":1,
"primary thyroid diffuse large B cell lymphoma":1,
"primary thyroid lymphoma":1,
"molecular genetics":1,
"Breast neoplasms":6,
"Laparoscopy":2,
"Mammaplasty":1,
"Mastectomy, radical":1,
"bioinformatics analysis":2,
"ryanodine receptor 2":1,
"thyroid carcinoma":27,
"Wnt":1,
"microRNA-300":1,
"regulation of nuclear pre-mRNA domain-containing protein 1B":1,
"Ablation techniques/methods":1,
"Neoplasm metastases":1,
"Spine":1,
"ALK":3,
"PDTC":1,
"anaplastic lymphoma kinase":1,
"poorly differentiated thyroid cancer":1,
"F-18-Dopa PET/CT":1,
"increased calcitonin":1,
"whole-body MRI":1,
"RFA":1,
"Thyroid ablation":1,
"benign nodule":1,
"laser ablation":1,
"malignant nodule":1,
"Core needle biopsy":4,
"Technique":1,
"Ultrasound":15,
"Aurora kinase inhibitor":1,
"PF-03814735":1,
"drug design":1,
"epigenetics":2,
"telomerase":1,
"mutant p53":1,
"phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α":1,
"target inhibitor":1,
"telomerase reverse transcriptase":1,
"Krebs cycle":1,
"PTEN hamartoma tumor syndrome":1,
"autism spectrum disorder":1,
"hereditary cancer":1,
"neurodevelopmental disorders":2,
"targeted metabolomics":1,
"autoimmune thyroiditis":1,
"causality":1,
"nuclear receptors":1,
"reverse transcription-semiquantitative PCR":1,
"CD44v6":1,
"TTF-1":2,
"large cell undifferentiated carcinoma":1,
"small cell undifferentiated carcinoma":1,
"undifferentiated lung carcinoma":1,
"ambient mass spectrometry":1,
"cancer diagnosis":1,
"metabolic profiles":1,
"molecular biomarkers":1,
"thyroid nodule diagnosis":1,
"2019":3,
"Adult":1,
"Anaplastic thyroid cancer":7,
"Asian - Japanese":1,
"Bronchoscopy*":1,
"CT scan":3,
"Coughing":1,
"FT3":1,
"FT4":1,
"Female":2,
"Haemoptysis":1,
"Histopathology":5,
"Japan":1,
"Levatinib":1,
"October":1,
"TSH":3,
"Thyroid antibodies":1,
"Thyroid transcription factor-1":4,
"Thyroid ultrasonography":3,
"Thyroxine (T4)":1,
"Triiodothyronine (T3)":1,
"Unique/unexpected symptoms or presentations of a disease":2,
"3,3,5-triiodo-L-thyronine (T3), L-thyroxine (T4), cancer proliferation":1,
"thyroid hormone":2,
"thyroid hormone receptor":1,
"Biological Sciences":1,
"Genomics":1,
"Fine needle aspiration":3,
"Molecular diagnositic techniques":1,
"Cancer registry":2,
"Incidence":5,
"Mortality":2,
"Surveillance":2,
"Papillary carcinoma thyroid":2,
"retropharyngeal node":1,
"tracheal infiltration":1,
"neck dissection":2,
"submental node":1,
"Atypia of undetermined significance":4,
"risk of malignancy":2,
"subcategory":1,
"thyroid cytopathology":1,
"Classification rate":1,
"Connection combination":1,
"Reinforcement residual network":1,
"Sal-deep network":1,
"Visual attention mechanisms":1,
"DNA fragility":1,
"DNA repair":2,
"DNA topoisomerases":1,
"TOP2 cleavage complex":1,
"chromatin organization":1,
"topoisomerases and disease":1,
"germline mutations":1,
"pathway analysis":1,
"predisposition markers":1,
"whole genome sequencing":1,
"BRAFV600E":2,
"RAS":6,
"convolutional neural network":1,
"deep learning":1,
"T-cell lymphoma":1,
"hand":1,
"peripheral":1,
"primary cutaneous":1,
"Differentiated thyroid carcinoma":6,
"Levothyroxine":2,
"TSH replacement therapy":1,
"TSH suppressive therapy":1,
"Thyroid-stimulating hormone":1,
"FIr-B/FOx":1,
"NEC":1,
"Neuroendocrine carcinoma":1,
"Subcutaneous metastasis":1,
"Triplet chemotherapy plus bevacizumab":1,
"Carcinoembryogenic antigen":1,
"Adiposity":1,
"Body mass index":1,
"Thyroid nodules":12,
"Visceral fat area":1,
"Acute invasive fungal infection":1,
"Ibrutinib":1,
"Mucormycosis":1,
"Iodine-131 therapy":1,
"Long-term follow-up":3,
"Nuclear medicine":1,
"Granular cell tumor":2,
"Pituicytoma":1,
"Transsphenoidal":1,
"genetic polymorphism":1,
"susceptibility":1,
"trefoil factor 3":1,
"frontolateral vertical partial laryngectomy":1,
"laryngeal carcinoma":1,
"laryngeal function reconstruction":1,
"titanium mesh":1,
"Benign thyroid disease":1,
"Menopause":1,
"Thyroid disorders":2,
"BRAF V600E":5,
"Extent of surgery":1,
"Molecular testing":3,
"Endoscopy":1,
"Narrow Band Imaging":1,
"Parathyroid Neoplasms":1,
"Video-Assisted Surgery":1,
"CD200":1,
"HNSCC":1,
"anaplastic and poorly differentiated thyroid carcinoma":1,
"oncolytic virus":1,
"liver cancer":1,
"oxidative stress":1,
"7th and 8th edition of AJCC staging system":1,
"Clinical significance":1,
"Pancreatic head and body-tail cancers":1,
"Multiple endocrine Neoplasia":2,
"Neurilemomma":1,
"Papillary carcinoma":7,
"Postoperative complications":1,
"Cancer genetics":1,
"Colon cancer":1,
"BMI":1,
"risk factor":1,
"complete response":1,
"immune adverse events":1,
"nephrectomy":2,
"nivolumab":2,
"renal cell carcinoma":2,
"thyroid dysfunction":2,
"vitiligo":1,
"second primary cancer":1,
"GPR68":1,
"OGR1":1,
"antibody":2,
"neuroendocrine":1,
"tumours":1,
"epidemiology":3,
"structural equation models":1,
"water":1,
"HMGA2":1,
"molecular markers":2,
"preoperative diagnosis":1,
"Androgen receptor":1,
"Androgen signal":1,
"PSA":1,
"ACR TI-RADS":1,
"American Thyroid Association (ATA) guidelines":1,
"Indeterminate":1,
"Case report":1,
"MEN type 1":1,
"MEN type 4":1,
"Parathyroid carcinoma":2,
"Pituitary adenoma":2,
"Pituitary apoplexy":2,
"AJCC 8th edition Cancer Staging Manual":1,
"Extra thyroid extension (ETE)":1,
"Locally advanced thyroid cancer":1,
"Well-differentiated thyroid carcinoma (WDTC)":1,
"Hashimoto’s thyroiditis":1,
"PTPRC":1,
"locally invasive thyroid tumors":1,
"multikinase inhibitors":2,
"neoadjuvant therapy":1,
"unresectable thyroid tumors":1,
"pathology":2,
"ratio":2,
"diagnostic techniques":1,
"amyloid":1,
"carcinoembryonic antigen":2,
"hyperparathyroidism":4,
"men2":1,
"pheochromocytoma":2,
"Endocrine Oncology":1,
"parathyroid disease":1,
"parathyroidectomy":2,
"Low-risk differentiated thyroid cancer":1,
"Radioiodine treatment":1,
"Recurrence":8,
"Relapse":1,
"CT":2,
"DTC":1,
"MRI":1,
"Post-therapeutic whole-body scan (WBS) with I-131":1,
"Follicular":2,
"Mandible":1,
"Neoplasm metastasis":2,
"aloperine":1,
"131I treatment":1,
"cohort studies":1,
"diagnostic whole body scan":1,
"Doppler ultrasonography":1,
"neoplasms":6,
"thyroid gland":13,
"Associated lesions":1,
"Microcarcinoma":3,
"Thyroid malignancies":1,
"Variants":2,
"EFVPTC":1,
"Encapsulated":1,
"NIFTWP":1,
"Non-invasive follicular":1,
"Re-nomenclature":1,
"Ectopic thyroid":1,
"Lingual thyroid":1,
"Lingual thyroid carcinoma":1,
"Bethesda classification":1,
"FNAC":2,
"TIRAD":1,
"Thyroid swelling":1,
"USG":1,
"Central lymph node dissection":1,
"Lymph node metastasis":9,
"Hypocalcemia":2,
"Recurrent laryngeal nerve injury":1,
"Surgical complications":1,
"Vocal cord palsy":1,
"clinical evidence":1,
"endocrine tumors":1,
"lithium":1,
"mechanism of action":1,
"pre-clinical evidence":1,
"CREB1":1,
"Lin28":1,
"miR-638":1,
"Iodine-refractory":1,
"Regorafenib":1,
"Myoma":1,
"Rising thyroglobulin":1,
"Tumor spread":1,
"anoikis":1,
"integrin β4":1,
"lymphovascular tumor thrombus":1,
"Neoadjuvant chemotherapy":1,
"Pathological complete response":1,
"Tumor recurrence":2,
"EFEMP2":1,
"Focus Harmonic Scalpel":1,
"Hypocalcaemia":1,
"Hypoparathyroidism":3,
"Pituitary metastasis":1,
"minimally invasive follicular thyroid carcinoma":1,
"medullary carcinoma":1,
"therapy":1,
"Chemotherapy":4,
"HCV reactivation":1,
"Hepatitis C virus (HCV)":1,
"Toxicity":2,
"68Ga-PSMA":1,
"prostate cancer":1,
"synchronous primary malignancy":1,
"Emergency endocrine disease":1,
"Intensive care":1,
"Pheochromocytoma multisystem crisis":1,
"Thyrotoxic crisis":1,
"Lymphangiogenesis":1,
"Lymphatic vessel density":1,
"Melanoma":3,
"Prediction":1,
"VEGF-C":1,
"Biopsy, fine-needle":1,
"Clinical hypothyroidism":1,
"Lymphocytic thyroiditis":1,
"Thyroid function tests":1,
"Hodgkin lymphoma":1,
"childhood":2,
"screening recommendations":1,
"subsequent malignant neoplasm (SMN)":1,
"firefighter":1,
"firefighting":1,
"review":2,
"Lingual lymph node":1,
"head and neck squamous cell carcinoma":1,
"locoregional control":1,
"tongue squamous cell carcinoma":1,
"Extrathyroidal invasion":1,
"Lymph node metastases":1,
"Recurrence-free survival":1,
"Vascular invasion":1,
"Diffusion-weighted imaging":2,
"Elasticity imaging techniques":1,
"Positron emission tomography/computed tomography":1,
"Ultrasound imaging":1,
"3,3',5’-triiodo-L-thyronine":1,
"Integrin αvβ3":2,
"glioblastoma":2,
"breast cancer (BRCA)":1,
"long noncoding RNA":1,
"prognostic":1,
"protein-coding gene (PCG)":1,
"signature":2,
"immunocytes":1,
"molecular subtypes":1,
"peripheral blood parameter":1,
"elastography":3,
"strain ratio":1,
"2型糖尿病":1,
"type 2 diabetes":1,
"癌症":1,
"风险":1,
"FNA":5,
"Hürthle cell":1,
"Oxyphilic cell":1,
"AKT/mTOR signaling pathway":1,
"aristaless-like homeobox 4":1,
"long intergenic non-protein coding RNA 313":1,
"gynecomastia":1,
"male breast cancer":1,
"management":2,
"testosterone":1,
"LRRK2":1,
"long noncoding RNA RP11-476D10 1":1,
"microRNA-138-5p":1,
"autopsy":1,
"cause of death":1,
"forensic pathology":1,
"forensic science":1,
"hepatic hemangioma":1,
"pulmonary thromboembolism":1,
"sudden collapse":1,
"EBV":1,
"herpesvirus type 4":1,
"thyroid tumor":1,
"viral load":1,
"False-negative rate":1,
"Size":1,
"≥4 cm":1,
"menin":1,
"Disease-specific survival":1,
"Lobectomy":1,
"Older adults":1,
"Surgery":4,
"18-FDG PET-CT":1,
"Cystic adenopathy":1,
"Nasopharyngeal cancer":1,
"Oropharyngeal cancer":2,
"Thyroid papillary carcinoma":2,
"Analgesia":1,
"Postoperative pain management":1,
"TOETVA":2,
"Thyroid surgery":4,
"VAS":1,
"cabozantinib":3,
"liver dysfunction":1,
"population pharmacokinetics":1,
"Central neck dissection":1,
"Local recurrence":1,
"Multiple primary tumors":1,
"PARP4":1,
"PARP4P2":1,
"Pseudogene":1,
"RAP1B":1,
"miR-206":2,
"Disparity":1,
"dermatologic toxicity":1,
"immune checkpoint inhibitor":1,
"immune-related adverse events":1,
"lichenoid dermatitis":1,
"mycosis fungoides":1,
"Athyreotic patients":1,
"Thyrotropin":2,
"Triiodothyronine":1,
"Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Thyroid cytology":1,
"Thyroid ultrasound":2,
"Diabetes insipidus":1,
"Hypothalamus":1,
"Magnetic resonance imaging":2,
"Pituitary stalk sectioning":1,
"Reconstitution":1,
"Recovery":1,
"Distant metastases":1,
"Multiple distant organ system metastases":1,
"Radioactive iodine therapy":2,
"intrathyroidal thymic carcinoma":1,
"neuroendocrine differentiation":1,
"Anatomy":1,
"SDPR":1,
"mechanism":1,
"tumor suppressor gene":1,
"Anaplastic thyroid carcinoma":9,
"CCL3":1,
"CCR5":1,
"MMP-1":1,
"Platelet":2,
"Breast-conserving surgery":1,
"Ductal carcinoma in situ":1,
"Postoperative radiotherapy":3,
"Afirma gene expression classifier":1,
"Hurthle cells":1,
"fine needle aspiration, thyroid cytopathology, molecular testing":1,
"indeterminate thyroid cytology":1,
"Gastroenteropancreatic neuroendocrine tumors":1,
"Imaging":2,
"Medullary thyroid cancer":4,
"Etiology":1,
"Thyroid disease":1,
"Thyroid tissue":1,
"Toxic/essential trace metals":1,
"Neuroendocrine tumors":1,
"Staging":1,
"Cytogenetic techniques":1,
"Genetic profile":1,
"Molecular biology":1,
"Tumor cell line":1,
"cytopathology":1,
"endocrine pathology":1,
"aberrant thyroid tissue":1,
"incidental finding":1,
"neck metastases":1,
"occult metastases":1,
"DDR1":1,
"DDR2":1,
"Discoidin domain receptors":1,
"Insulin receptor":1,
"Insulin-like growth factor system":1,
"Insulin-like growth factor-2":1,
"Isoform A":1,
"Anti-HER2 antibody":1,
"Boron neutron capture therapy":1,
"Gold nanoparticle-boron cage assemblies":1,
"Clinicopathological parameters":1,
"Strap muscle":1,
"Suprasternal space lymph node":1,
"Surgical morbidity":1,
"Glycomics":1,
"Glycosylation":1,
"Mass spectrometry":1,
"N-Glycans":1,
"Ambulatoire":1,
"Chirurgie":1,
"Facteurs de risque":1,
"Outpatient":1,
"Risk factors":4,
"Thyroïde":1,
"Metabolic diseases":1,
"Oxidants":1,
"Pyruvate kinase M2":3,
"Redox homeostasis":1,
"Warburg effect":2,
"propensity score matching":2,
"transcriptome":2,
"deglutition disorders":2,
"jaw exercise":1,
"jaw range of motion":1,
"quality of life":1,
"trismus":1,
"DNER":1,
"Girdin/PI3K/AKT axis":1,
"Hürthle cell carcinoma":1,
"Oncocytic":1,
"Oxyphilic papillary thyroid cancer":1,
"GLP-1 receptor agonists":1,
"Randomized controlled trials":1,
"Type 2 diabetes mellitus":1,
"CyberKnife":1,
"bone metastasis":1,
"stereotactic radiotherapy":2,
"TPO gene":1,
"congenital goiter":1,
"congenital hypothyroidism":1,
"thyroid dyshormonogenesis":1,
"computed tomography":1,
"papillary thyroid microcarcinoma":6,
"cancer cure":1,
"cancer survivors":1,
"life expectancy":1,
"time to cure":1,
"Follicular lesions of undetermined significance":1,
"Mutational profile":1,
"Thyroid FNA":1,
"immediate surgery":1,
"questionnaire survey":1,
"ATSP":1,
"HLRCC":1,
"redox regulation":1,
"aerodigestive tract":1,
"extrathyroidal extension":4,
"positive margins":1,
"ETS factors":1,
"MAPK":1,
"123I scan":1,
"124I PET/CT":1,
"131I scan":1,
"detection":1,
"APC gene mutation":1,
"CMV–PTC":1,
"FAP":1,
"multifocality":1,
"indeterminate cytology":1,
"molecular diagnostics":2,
"DNA methylation":2,
"Histone modification":1,
"Fine-needle aspiration biopsy":1,
"Indeterminate nodule":1,
"McGill Thyroid Nodule Score":1,
"4 T1 cells":1,
"MAPK pathway":1,
"Triple-negative breast cancer":2,
"Tumor-associated macrophages":1,
"hemithyroidectomy":3,
"low-risk thyroid cancer":1,
"neck ultrasonography":1,
"total thyroidectomy":3,
"UPP1":1,
"epithelial-mesenchymal transition (EMT)":2,
"CD8":1,
"FoxP3":1,
"tumor bed":1,
"tumor stroma":1,
"cancer stem cell":1,
"epithelial-mesenchymal transition":2,
"lateral neck-node metastasis":1,
"lymphatic spread":1,
"thyroid papillary microcarcinoma":1,
"FOXF1":1,
"bioinformatic analysis":2,
"Chinese Han population":1,
"IL1A":1,
"IL1B":1,
"Polymorphisms":1,
"Adverse pathological feature":1,
"Early stage oral cavity cancer":1,
"dental X-rays":1,
"dental radiography":1,
"glioma":3,
"meningioma":1,
"systematic review":3,
"head and neck neoplasms":2,
"survival analysis":3,
"transplants":1,
"thyroid follicles":1,
"thyroid function":2,
"malignant pleural effusion":1,
"pleural thyroglobulin":1,
"clinicopathological feature":1,
"sequence":1,
"Afirma":1,
"fine-needle aspiration (FNA)":2,
"gene expression classifier (GEC)":1,
"genomic sequencing classifier (GSC)":1,
"NIFTP":4,
"Lnc-SLC4A1-1":1,
"NF-κB/CXCL8":1,
"cancer cell metastasis":1,
"cell apoptosis":2,
"CD1d":1,
"NKT cell":1,
"lymphocyte infiltration":1,
"intensity-modulated radiotherapy":1,
"prevalence":1,
"bilateral lateral neck metastasis":1,
"one lobe":1,
"Low-risk":1,
"Observation":1,
"Mucinous carcinoma":1,
"Ovarian carcinoma":1,
"Small-cell carcinoma":1,
"SEER":2,
"competing risk":1,
"Monte Carlo simulation":2,
"effective dose":1,
"four-dimensional cone-beam computed tomography":1,
"secondary cancer risk":1,
"chemoradiotherapy":1,
"circulating tumor DNA":1,
"focal adhesion":1,
"liquid biopsy":1,
"whole-exome sequencing":2,
"Micro-carcinome papillaire de la thyroïde":1,
"Métastase":1,
"Proteomics":3,
"Protéomique":1,
"Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis":1,
"differentially expressed genes":3,
"lung cancer":2,
"protein-protein interaction":1,
"sphingosine kinase 1":1,
"Biomarker testing":1,
"NTRK gene fusion":1,
"precision medicine":1,
"soft tissue sarcoma":1,
"BRAF inhibitor":1,
"MAPK inhibitor":1,
"MEK inhibitor":1,
"mitogen-activated protein kinase inhibitor":1,
"radioiodine refractory thyroid cancer":1,
"radioiodine therapy":2,
"Chronic obstructive pulmonary disease":1,
"Enolase":1,
"Neuron-specific enolase":1,
"Pulmonary alveolar proteinosis":1,
"Solitary pulmonary nodules":1,
"FOXM1":1,
"LINC01410":1,
"miR-3619-5p":1,
"llamas":1,
"CCDC6":1,
"alectinib":1,
"I-131 postablation scan":1,
"SPECT/CT":1,
"whole body scan":1,
"IRAK1":1,
"NFKB1":1,
"NFKBIA":1,
"mir-146a":1,
"evolution":1,
"exome sequencing":1,
"multi-tissue":1,
"phylogeny":1,
"subclonal mutations":1,
"PAX8-PPARG":1,
"American Thyroid Association guidelines":1,
"radioactive iodine ablation":1,
"Initial manifestation of malignancy":1,
"Spinal metastasis":1,
"Surgical treatment":2,
"Alternative splicing":1,
"Curcumin":1,
"PKM":1,
"cell growth":1,
"clinicopathological characteristics":3,
"diagnostic value":1,
"microRNA-130a":1,
"microRNA-203":1,
"AKT/STAT3 signaling pathway":1,
"Competing endogenous RNA":1,
"Long non-coding RNA 01296":1,
"Musashi 2":1,
"microRNA-143-3p":1,
"PTP1B":1,
"UCA1":2,
"Follicular thyroid cancer":3,
"PTEN":2,
"Signet ring cell":1,
"NOP53":1,
"genetic abnormalities":1,
"oncogenic mutations":1,
"CHEK2 mutation":1,
"response to therapy":1,
"Circulating tumor cells":1,
"Endoscopic breast surgery":1,
"Micrometastases":1,
"Neoplastic cells":1,
"Open surgery":1,
"head and neck surgery":1,
"otolaryngology / ENT":1,
"irradiation":1,
"pneumonitis":1,
"Intrathyroidal parathyroid adenomas":1,
"Kidney transplantation":2,
"BRAFV600E mutations":1,
"RAS mutation":1,
"classic variant":1,
"follicular variant":1,
"genetic drivers":1,
"sonographic features":1,
"genetics":2,
"PROX1":1,
"angiogenesis":2,
"metabolism":1,
"TKIs":1,
"Tyrosine kinase inhibitors":3,
"progression free survival":1,
"Enhancer of zeste homolog 2":1,
"Estrogen receptor alpha":1,
"ATC":1,
"miR-155":1,
"Benign thyroid nodules":1,
"DLG1-AS1":1,
"miR-199a-3p":1,
"Au nanoparticles":1,
"Dissolved oxygen":1,
"Electrochemiluminescence":1,
"G-C3N4":1,
"Glassy carbon electrode":1,
"Peroxodisulfate":1,
"Polyaniline":1,
"Ratiometric assay":1,
"Immune checkpoint inhibitors":1,
"Oligometastases":1,
"Pathologic complete response":1,
"ING4":1,
"miR-765":1,
"Ectopic mediastinal parathyroid tumor":1,
"Technetium-99 m methoxyisobutyl isonitrile scintigraphy":1,
"Video-assisted thoracoscopic surgery":1,
"Contrast media":1,
"Liver":2,
"Positron emission tomography computed tomography":1,
"data analysis":1,
"trend":1,
"Cervical lymph node dissection":1,
"Cervical lymph node metastasis":2,
"thyroid malignancy":2,
"NTRK fusions":1,
"ancillary testing":1,
"next-generation sequencing":1,
"tyrosine kinase inhibitor":3,
"MTFR2":1,
"Thyroid papillary cancer haemogram":1,
"dose volume parameters":1,
"radiation therapy":1,
"Chest wall":1,
"Follicular thyroid carcinoma":4,
"Lymph node":4,
"Clear cell renal cell carcinoma":1,
"Metastases":3,
"Differentiated thyroid carcinomas":1,
"Follow-up":2,
"Growth rates":1,
"Thyroid adenomas":1,
"Thyroid carcinomas":1,
"Tumor growth":2,
"Parathyroid adenocarcinoma,":1,
"asymptomatic,":1,
"intrathyroidal,":1,
"normocalcemic":1,
"cancer treatment":1,
"curability and cancer epidemiology":1,
"theragnostics":1,
"nerves":1,
"neurotrophin":1,
"proNGF":2,
"Polymerase chain reaction":1,
"Proto-oncogene proteins B-raf":1,
"Biopsy-rinse":1,
"Serum":1,
"Conventional ultrasound":1,
"Thyroid micro-nodules":1,
"Ultrasonic elastography":1,
"Chromogranin A":1,
"Fine needle aspiration biopsy":1,
"Goitre":1,
"Goitre (multinodular)":1,
"Italy":1,
"Lymph node dissection":2,
"Male":1,
"New disease or syndrome: presentations/diagnosis/management":1,
"November":1,
"Oncology":1,
"PET scan":1,
"Radioiodine":2,
"S-100 protein*":1,
"White":2,
"recombinant human TSH*":1,
"18F-FDG-PET/CT":1,
"PTC":1,
"palliative therapy":1,
"rare distant metastases":1,
"follicular adenoma":1,
"Clinicopathological features":2,
"Standardized incidence ratios":1,
"leukemia":1,
"pediatric cancers":1,
"second malignant neoplasms":1,
"AMPK":2,
"LKB1":1,
"PKA":1,
"mouse models":1,
"Craniofacial":1,
"TCGA":1,
"progression-free interval":1,
"lymph nodes posterior to the right recurrent laryngeal nerve":1,
"predict model":1,
"dog":1,
"galectin-3":2,
"oral cavity":1,
"MTDH":1,
"MiR-136-5p":1,
"microRNA microarray and microRNA-sequencing":1,
"endoscopic surgery":1,
"minimally invasive video-assisted technique":1,
"parapharyngeal lymph node metastases":1,
"parapharyngeal space":1,
"Papillary thyroid carcinoma (PTC)":3,
"Pre-sternal":1,
"Retrosternal":1,
"Substernal":1,
"Biopsy":1,
"Fine-needle":1,
"melatonin":1,
"melatonin receptor":1,
"miR-3619-3p":1,
"COX7A1":1,
"breast invasive carcinoma":1,
"methylation-driven genes":1,
"cluster miR-17-92":1,
"differentiation":1,
"miR-19a":1,
"poor prognosis":1,
"head and neck":1,
"Clinical outcome":1,
"pediatric differentiated thyroid carcinoma":1,
"Biomarkers":3,
"Bladder cancer":3,
"Estrogen metabolites":1,
"Infertility":1,
"Schistosoma haematobium":1,
"Breast":1,
"fat-to-lesion speed ratio":1,
"gland-to-lesion speed ratio":1,
"shear wave speed imaging":1,
"disease-free survival":1,
"human epidermal growth factor receptor-2":1,
"sentinel lymph node metastasis":1,
"Bethesda system of reporting thyroid cytology":1,
"malignancy rate":1,
"Shenzhen":1,
"cervical carcinoma":1,
"mast cell":1,
"systemic mast cell activation disease":1,
"systemic mast cell activation syndrome":1,
"systemic mastocytosis":1,
"Ki-67":1,
"atypical carcinoid":1,
"carcinoid":1,
"neuroendocrine neoplasm":1,
"orthopedia homeobox protein (OTP)":1,
"thyroid transcription factor 1 (TTF-1)":1,
"favorable outcome":1,
"solid tumor":1,
"tumor-infiltrating CD57+ lymphocytes":1,
"Radiotherapy":3,
"Nasopharynx":1,
"Papillary adenocarcinoma":1,
"Thyroid-like low-grade nasopharyngeal papillary carcinoma":1,
"cachexia":1,
"exosomes":1,
"tumour progression":1,
"Central airway obstruction":1,
"Oxygen reserve index (ORi)":1,
"Pulse oximetry":1,
"Rigid bronchoscopy":1,
"Tracheal stent":1,
"extraocular muscle":1,
"orbitopathy":1,
"paraneoplastic syndrome":2,
"HbA1c":1,
"irAE":1,
"type 1 diabetes mellitus":1,
"Coffee":1,
"EPIC":1,
"Intake":1,
"Tea":1,
"radioactive treatment":1,
"thermal ablation":2,
"toxic adenoma":1,
"Anaplastic carcinoma":1,
"ETV6 gene rearrangement":1,
"Mammary analogue secretory carcinoma":1,
"Ultrasound examination":1,
"Inhibitors":1,
"Mutations":1,
"Signaling":1,
"Therapeutics":2,
"Drug therapy":1,
"Pregnancy":1,
"multiple endocrine neoplasia type 2B":1,
"submucosal neuroma":1,
"Adamantinoma-like Ewing sarcoma":1,
"Ewing sarcoma":1,
"Sarcoma":1,
"Follow-up studies":1,
"Neoplasms, vascular tissue":1,
"STAT6":1,
"Solitary fibrous tumors":1,
"RET mutation":1,
"spontaneous regression":1,
"vandetanib":3,
"ETV6/NTRK3":1,
"Tracheal resection":1,
"Tracheoplasty":1,
"Cancer risks":1,
"Fluoroscopy":1,
"Radiation exposure":1,
"ZEB1":1,
"Zinc finger E-box-binding homeobox 1":1,
"miR-429":1,
"aerodigestive tract invasion":1,
"aggressive thyroid cancer":1,
"tracheoesophageal groove":1,
"Euthyroid":1,
"breast carcinoma":1,
"carcinome mammaire":1,
"otoraplin":1,
"otorapline":1,
"prolifération":1,
"Recurrent nerve injury":1,
"Reoperative thyroid surgery":1,
"Color Doppler ultrasound":1,
"Malignant thyroid nodule":1,
"Papillary cancer":1,
"Thyroiditis":1,
"Cytokeratin 19":1,
"disseminated tumor cells":1,
"neoplasm diagnosis":1,
"neoplasm prognosis":1,
"miR-15a":1,
"Integrated bioinformatics analysis":1,
"MMP13":1,
"MMP3":1,
"Adverse effects":2,
"Antilles":1,
"Chlordecone":1,
"Chlordécone":1,
"Effets indésirables":1,
"Pesticides":1,
"Prostatic neoplasms":1,
"Troubles du développement neurologique":1,
"Tumeurs de la prostate":1,
"West Indies":1,
"14-3-3ζ":1,
"nicotinamide phosphoribosyltransferase":1,
"tamoxifen resistance":1,
"KRAS":1,
"Let-7g":1,
"TN":1,
"rs712":1,
"BRAF V600E mutation":2,
"microarray analysis":1,
"papillary thyroid carcinomas":3,
"bioinformatics":1,
"robust rank aggregation":1,
"Central hyperthyroidism":1,
"Free T3":1,
"Free T4":1,
"Resistance to thyroid hormones":1,
"Somatostatin analogs":1,
"TSH-oma":1,
"Thyrotropin-secreting pituitary adenoma":1,
"Transsphenoidal surgery":1,
"magnetic field":1,
"needle guidance":1,
"Levothyroxine dose adjustment":1,
"Real life":1,
"TSH variability":1,
"Chinese":1,
"poorly differentiated thyroid carcinoma":3,
"Phonatory function":1,
"Recurrent laryngeal nerve":1,
"Well-differentiated thyroid carcinoma":1,
"childhood cancer survivor":1,
"ceRNA network":1,
"Quality of care":1,
"Obesity":2,
"CpG signature":1,
"DNA methylation profiling":1,
"long non-coding RNA H19":2,
"molecular therapy":1,
"tumorigenesis":1,
"c-ret":1,
"epigenomics":1,
"genes":1,
"medullary":2,
"proto-oncogene proteins":1,
"Patient-doctor relationship":1,
"Preoperative":1,
"Qualitative":1,
"Reassurance":1,
"Anaplastic thyroid carcinoma (ATC)":1,
"Smad":1,
"epithelial-to-mesenchymal transition":1,
"transforming growth factor":1,
"Indeterminate nodules":2,
"MicroRNA-4500":1,
"Papillary thyroid cancer (PTC)":2,
"Plexin C1 (PLXNC1)":1,
"Sonography":1,
"TERT C228T mutation":1,
"clinic-pathological characteristics":1,
"pediatric papillary thyroid cancer":1,
"2-dimensional difference gel electrophoresis":1,
"Serological proteome analysis":1,
"Glial fibrillary acidic protein":1,
"astrocytopathy":1,
"central nervous system":1,
"Hub genes":1,
"Weighted gene co-expression network analysis":1,
"Acinar cell carcinoma":1,
"Differential diagnosis":2,
"Morphology":1,
"Adequacy":1,
"Nodal yield":1,
"De Quervain's":1,
"cytological features":1,
"subacute granulomatous thyroiditis":1,
"pediatric thyroid cancer":1,
"Aggressiveness":1,
"Epithelial to mesenchymal transition":3,
"EZH2":1,
"H3K27me3":1,
"1H-NMR":1,
"FAAS":1,
"IR":1,
"MTT assay":1,
"Nickel":1,
"Schiff base":1,
"Bethesda thyroid cytopathology":1,
"cell block":1,
"ARMS-PCR":1,
"FVPTC":1,
"follicular variant of papillary carcinoma":1,
"noninvasive EFVPTC":1,
"high sensitive":1,
"prognostic biomarkers":2,
"Deiodinase":1,
"encapsulated variant":1,
"machine learning":1,
"radiomics":1,
"HAM-1":1,
"In situ hybridization":1,
"PCA3":1,
"PCR array":1,
"RT-PCR":1,
"Heterogeneity":1,
"RNA-seq":1,
"anthropometric parameters":1,
"case-control study":1,
"Korea":1,
"lesion-based evaluation":1,
"progressive disease":1,
"cyto-histological correlation":1,
"fine needle cytology":1,
"mutational analysis":1,
"thyroid cancer treatment":1,
"ultrasound features":1,
"Flow cytometry":1,
"Immunoglobulin heavy chain rearrangement":1,
"Karyotypic analysis":1,
"Mucosa-associated lymphoid tissue":1,
"Thyroid lymphoma":1,
"Cardiac myxoma":1,
"Carney complex":1,
"Pituitary tumor":1,
"benign thyroid disorder":1,
"immune system":1,
"E-cadherin":3,
"REGγ":1,
"Prognostic factors for survival":1,
"Staging systems":1,
"Prognostic factors":1,
"RET proto-oncogene mutation":1,
"health insurance":1,
"healthcare disparities":1,
"overtreatment":1,
"fine-needle biopsy":1,
"Clinical knowledge":1,
"Convolutional neural networks":1,
"Ultrasound image":1,
"Glycolysis metabolism":1,
"Membrane penetration":1,
"Multivalent helical polypeptide":1,
"Photothermal therapy":1,
"Starvation therapy":1,
"siRNA delivery":1,
"Colorectal cancer":1,
"DOT1L":1,
"H3K79me2":1,
"Stemness":2,
"miR-133b":1,
"AUS/FLUS":1,
"Thyroid fine needle aspiration":1,
"Epiduritis":1,
"Metastatic spreading":1,
"Spine metastases":1,
"Vertebrae":1,
"Astraxanthin":1,
"HMG-CoAR":1,
"Keap1":1,
"NF-kB":1,
"Nrf-2":1,
"antioxidant":1,
"metabolizing enzymes":1,
"solid lipid nanoparticles":1,
"PSMB8":1,
"miR-451a":1,
"miRNAs":1,
"cell division":1,
"geriatric oncology":1,
"oncogenesis":1,
"BCPAP cells":1,
"BRAF kinase":1,
"Iodine":2,
"GAP43":1,
"oncogene":1,
"optical coherence tomography":1,
"parathyroid":2,
"tissue biopsy":1,
"hypopharyngeal cancer":1,
"miRNA":1,
"score":1,
"endocrine":1,
"Sistrunk’s procedure":1,
"Thyroglossal cyst carcinoma":1,
"circulating tumor cells (CTCs)":1,
"Surgicel":1,
"foreign-body reaction":1,
"oxidized cellulose":1,
"pseudotumor":1,
"Hedgehog pathway":1,
"LncRNA LINC01510":1,
"SHH":1,
"miR-335":1,
"radioiodine-refractory differentiated thyroid carcinoma":1,
"salvage treatment":1,
"oral contraceptive use":1,
"reproductive factors":1,
"carbon-ion radiotherapy":1,
"out-of-field dose":1,
"pediatric cancer":2,
"Encapsulated follicular variant of papillary thyroid carcinoma":1,
"CDK12":1,
"Ser2 phosphorylation of pol II CTD":1,
"Super enhancer":1,
"THZ531":1,
"BRAF protein, human":1,
"Protein-tyrosine kinase":1,
"Dedifferentiated thyroid cancer":1,
"IL-6/STAT3 signaling pathway":1,
"nevirapine":1,
"Anaplastic thyroid cancer (ATC)":1,
"Anti-PD-1 antibody":1,
"Checkpoint inhibitor":1,
"Kidney transplant recipients":1,
"Pretransplant":1,
"Sanger sequencing":1,
"familial nonmedullary thyroid cancer":1,
"genetic mutation":1,
"targeted gene sequencing":1,
"TRIP13":1,
"TTC5":1,
"Tumor metastasis":1,
"Palliative surgery":1,
"Pulmonary adenocarcinoma":1,
"Rectal metastasis":1,
"growth activity":1,
"kinetic analysis":1,
"papillary microcarcinoma":1,
"lymphocyte":1,
"monocyte":1,
"neutrophil":1,
"thyrotoxicosis":1,
"Assessment":1,
"Cardiovascular risk":1,
"Secondary hypertension":1,
"Target organ damage":1,
"Intratumor heterogeneity":1,
"magnetic probe":1,
"sentinel lymph node biopsy":1,
"superparamagnetic iron oxide":1,
"Cell":1,
"double-blind":1,
"logistic regression model":1,
"metabolomics":1,
"False-negative diagnoses":1,
"False-positive diagnoses":1,
"Angioinvasion":1,
"Extranodal extension":1,
"TERT promoter":1,
"Cowden syndrome":1,
"Rare papillary thyroid carcinoma subtypes":1,
"TERT promoter mutation":1,
"Dynamic risk stratification":1,
"Treatment":1,
"Aggressive":1,
"endoscopic thyroidectomy":2,
"Metastatic":1,
"Skin":1,
"Germ cell tumors":1,
"Malignant struma ovarii":1,
"Struma ovarii":2,
"Struma ovarii with malignant transformation":1,
"epithelial–mesenchymal transition":1,
"miR-25":1,
"echogenicity":1,
"nodular goiters":1,
"ultrasonic diagnosis":1,
"ultrasound gray scale ratio":1,
"chromosomal instability":1,
"gene expression":1,
"Cadmium":1,
"Chromium":1,
"Cobalt":1,
"Copper":1,
"Lead":1,
"Thyroid diseases":1,
"Zinc":1,
"Small cell lung cancer":1,
"Systemic review and meta-analysis":1,
"Communication":1,
"Coping":1,
"Distress":1,
"Influence":1,
"deceased donor":1,
"transplantation":1,
"BLU-667":1,
"Fusion":1,
"LOXO-292":1,
"Pralsetinib":1,
"Rearrangement":1,
"Selpercatinib":1,
"Solid":1,
"Naringin":1,
"PI3K/AKT pathway":1,
"breast tumor":1,
"double-load and -response":1,
"drug delivery":1,
"mesoporous silica nanoparticles (MSNs)":1,
"proapoptotic peptide":1,
"Carpesium abrotanoides L":1,
"medicinal&nbsp":1,
"plant":1,
"Bilateral diffuse uveal melanocytic proliferation":1,
"infrared imaging":1,
"Adverse vascular remodeling":1,
"Angiopoietin2":1,
"Cardiovascular disease":1,
"Low T3 state":1,
"thyroid cancer diagnostic imaging":1,
"LINC00152":1,
"SNHG12":1,
"clinicopathologic characteristics":1,
"long noncoding RNAs":1,
"progression":2,
"distant metastasis":1,
"Central compartment dissection":1,
"ethanol":1,
"nerve injury":1,
"hyperfunctioning thyroid carcinoma":1,
"malignant hot thyroid nodule":1,
"MET":1,
"circ5912":1,
"CADs":1,
"Experienced radiologists":1,
"Balance factor":1,
"Generalized clustering":1,
"Object segmentation":1,
"Spatial structure":1,
"DNA methylation profile":1,
"gene expression profile":1,
"pathogenic biomarkers":1,
"Ovarian cancer":1,
"miR-552":1,
"Tetrac":1,
"mesenchymal stem cells":1,
"thyroid hormones":1,
"Del-1":1,
"developmental endothelial locus-1":1,
"miR-137":1,
"MALAT1":1,
"METTL3":1,
"YAP":1,
"YTHDF1/3":1,
"eIF3b":1,
"m6A Modification":1,
"miR-1914-3p":1,
"March1":1,
"ciRs-6":1,
"Apatinib":1,
"vascular endothelial growth factor receptor":1,
"Juxtaposed with another zinc finger gene 1":1,
"TAK1":1,
"Interleukin-22":1,
"Sox17":1,
"TRIM30":1,
"Tripartite-motif protein 30":1,
"PI3K/Akt/mTOR signaling pathway":1,
"osteoglycin":1,
"small leucine-rich proteoglycans":1,
"anesthesia":1,
"conduction":1,
"conscious sedation":1,
"deep sedation":1,
"radiofrequency ablation":4,
"radiography":1,
"﻿interventional":1,
"Central compartment lymph node dissection":1,
"Intact PTH (iPTH)":1,
"Morbidity":1,
"Calcium (serum)":1,
"Calcium (urine)":1,
"December":1,
"Fatigue":1,
"Hypercalcaemia":1,
"Hyperparathyroidism (primary)":1,
"PTH":1,
"Polydipsia":1,
"Polyuria":1,
"Pregnant adult":1,
"Saline":1,
"United Kingdom":1,
"Clinical effectiveness":1,
"accident at ChNPP":1,
"functional parameters":1,
"malignant tumors":1,
"mammary gland":1,
"structural parameters":1,
"Resection":1,
"BCL2":1,
"Deregulated miRNAs":1,
"Differentially expressed genes (DEGs)":1,
"hsa-miR-181a-5p":1,
"Breast tumours":1,
"breast reconstruction":1,
"oncoplastic breast-conserving surgery":1,
"patient reported outcome measures":1,
"study protocol":1,
"real-time quantitative polymerase chain reaction":1,
"stanniocalcin 2":1,
"metabolic disturbances":1,
"nutritional status":1,
"solid tumors":1,
"PI3K/AKT/mTOR pathway":1,
"TDRG1":1,
"gastric cancer":1,
"growth":1,
"lncRNA Linc-pint":1,
"lncRNA PTCSC3":1,
"frequency":1,
"statistics":1,
"Carcinoma larynx":1,
"Total laryngectomy":1,
"Near-total laryngectomy":1,
"Pyriform fossa":1,
"Discharging ulcer":1,
"Fatal":1,
"Squamous metaplasia":1,
"dose modification":1,
"sarcopenia":1,
"DIAPH1":1,
"GOLGA2":1,
"formin-like 1 (FMNL1)":1,
"mesenchymal subtype":1,
"pazopanib":1,
"sunitinib":1,
"GBS":1,
"Guillain-Barré Syndrome":1,
"paraneoplastic":1,
"progesterone receptor":1,
"Behavior":1,
"French Polynesia":1,
"atmospheric nuclear weapons test":1,
"food consumption":1,
"LINC00460":1,
"Raf1":1,
"miR-485-5p":1,
"Carcinoma espinocelular":1,
"Glândula tireoide":1,
"Laringe":1,
"Laringectomia":1,
"Laryngectomy":1,
"Larynx":1,
"Squamous cell carcinoma":2,
"Tireoidectomia":1,
"TERT promoter mutations":1,
"ACDF":1,
"Anterior cervical Discectomy and Fusion":1,
"C7/T1 anterior discectomy":1,
"Cervicothoracic junction":1,
"Bladder metastasis":1,
"Renal metastases":1,
"Sclerosing mucoepidermoid carcinoma with eosinophilia":1,
"V600E":1,
"Safety":1,
"Lateral circumflex femoral artery, descending branch":1,
"Microsurgery":1,
"Reconstructive surgical procedures":1,
"Surgical flaps":1,
"Tongue neoplasms":1,
"Guidelines":1,
"Ganglioneuroma":1,
"Multiple endocrine neoplasm (MEN)":1,
"Papillary thyroid carcinoma (PCT)":1,
"Paratesticular tumour":1,
"GLUT":1,
"Glucose metabolism":1,
"Tumor differentiation":1,
"multiple endocrine neoplasia type 2":1,
"MIRN34 microRNA":1,
"Receptor, Notch1":1,
"Triple negative breast neoplasms":1,
"Blood proteins":1,
"PAK4 inhibitor":1,
"selective inhibitors of nuclear export":1,
"selinexor":1,
"therapy resistance":1,
"diabetes":1,
"population study":1,
"matrix metalloproteinase-2":1,
"matrix metalloproteinase-9":1,
"tissue inhibitor of matrix metalloproteinase-1":1,
"EYA1":1,
"SIX1":1,
"STAT3 signal":1,
"ATA risk stratification systems":1,
"Indian population":1,
"Kerala":1,
"Outcome":1,
"Validation":1,
"Intramuscular levothyroxine":1,
"Levothyroxine therapy":1,
"Refractory hypothyroidism":1,
"Chronic diseases":1,
"Reliability":1,
"Self-reported":1,
"Test-retest":1,
"ca-125":1,
"dystrophic calcification":1,
"orphan annie eye nuclei":1,
"ovarian tumor":1,
"psammoma body":1,
"stained glass appearance":1,
"surgical debulking":1,
"3D ultrasound":1,
"parathyroid adenoma":1,
"dual-energy computed tomography (DECT)":1,
"ultrasonography (US)":1,
"contrast-enhanced ultrasonography":1,
"risk and prognosis":1,
"wide areas of China":1,
"thyroglobulin antibodies":1,
"Classical dendritic cells":1,
"Cross presentation":1,
"MHC I and II antigen presentation":1,
"Plasmacytoid dendritic cells":1,
"Th polarization":1,
"C cell":1,
"FOXA1":1,
"Latin America":1,
"Uruguay":1,
"carcinoma, transitional cell":1,
"noncommunicable diseases":1,
"stomach neoplasms":1,
"testicular germ cell tumor":1,
"testicular neoplasms":1,
"tobacco":1,
"trends":1,
"urinary bladder neoplasms":1,
"uterine cervical neoplasms":1,
"Cholesterol, HDL":1,
"IGF1 protein, human":1,
"IGF2 protein, human":1,
"Insulin":1,
"Insulin-Like Growth Factor I":1,
"Insulin-Like Growth Factor II":1,
"Obesity, Abdominal":1,
"insulin resistance":1,
"metabolic syndrome":1,
"shear wave elastography":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年第4季度论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
